ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,032Medicare Part D Prescriptions Filled, Including Refills
$577K Total Retail Price of All Prescriptions
347 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 483 370 S3
LEVOTHYROXINE SODIUM 383 338
OMEPRAZOLE 374 336
FUROSEMIDE 302 258
MELOXICAM 276 245
POTASSIUM CHLORIDE 275 238
AMLODIPINE BESYLATE 262 260
METOPROLOL SUCCINATE 247 224
CARVEDILOL 228 218
METFORMIN HCL 224 181
SIMVASTATIN 214 201
PRAVASTATIN SODIUM 195 180
ZOLPIDEM TARTRATE 176 150
TAMSULOSIN HCL 170 153
WARFARIN SODIUM 148 148
FAMOTIDINE 140 117
LISINOPRIL 134 109
LOSARTAN-HYDROCHLOROTHIAZIDE 129 122
TRAMADOL HCL 123 114
LOSARTAN POTASSIUM 119 113
TRAZODONE HCL 107 89
ESTRADIOL 101 71 R
FLUOXETINE HCL 100 75
GLYBURIDE 99 94 R
GLIMEPIRIDE 96 96
CITALOPRAM HBR 95 76
ALLOPURINOL 95 86
GABAPENTIN 95 70
CELEBREX 91 91
HYDROCHLOROTHIAZIDE 88 78
AZITHROMYCIN 83 75
NEXIUM 78 66
PREDNISONE 77 75
METOPROLOL TARTRATE 70 68
NAMENDA 69 69
FLUTICASONE PROPIONATE 68 61
ADVAIR DISKUS 66 51
AMLODIPINE BESYLATE-BENAZEPRIL 66 57
SPIRONOLACTONE 65 53
BISOPROLOL-HYDROCHLOROTHIAZIDE 63 63
ATORVASTATIN CALCIUM 63 56
NAPROXEN 61 42
TIZANIDINE HCL 60 26
AMITRIPTYLINE HCL 57 52 R
ISOSORBIDE MONONITRATE ER 56 52
CEFUROXIME 56 52
LANSOPRAZOLE 55 43
CLOPIDOGREL 54 50
ENALAPRIL MALEATE 53 53
PAROXETINE HCL 53 53
SPIRIVA 50 46
CRESTOR 50 50
RANITIDINE HCL 50 38
DONEPEZIL HCL 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.